Configuration of a High-Content Imaging Platform for Hit Identification and Pharmacological Assessment of JMJD3 Demethylase Enzyme Inhibitors

The biological complexity associated with the regulation of histone demethylases makes it desirable to configure a cellular mechanistic assay format that simultaneously encompasses as many of the relevant cellular processes as possible. In this report, the authors describe the configuration of a JMJD3 high-content cellular mechanistic imaging assay that uses single-cell multiparameter measurements to accurately assess cellular viability and the enzyme-dependent demethylation of the H3K27(Me)3 mark by exogenously expressed JMJD3. This approach couples robust statistical analyses with the spatial resolving power of cellular imaging. This enables segregation of expressing and nonexpressing cells into discrete subpopulations and consequently pharmacological quantification of compounds of interest in the expressing population at varying JMJD3 expression levels. Moreover, the authors demonstrate the utility of this hit identification strategy through the successful prosecution of a medium-throughput focused campaign of an 87 500-compound file, which has enabled the identification of JMJD3 cellular-active chemotypes. This study represents the first report of a demethylase high-content imaging assay with the ability to capture a repertoire of pharmacological tools, which are likely both to inform our mechanistic understanding of how JMJD3 is modulated and, more important, to contribute to the identification of novel therapeutic modalities for this demethylase enzyme.

[1]  Haruhiko Koseki,et al.  Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells , 2007, Nature Cell Biology.

[2]  Paul Martin,et al.  Epigenetic reprogramming during wound healing: loss of polycomb‐mediated silencing may enable upregulation of repair genes , 2009, EMBO reports.

[3]  K. Helin,et al.  The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma , 2011, Oncogene.

[4]  T. Beckers,et al.  A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening. , 2008, Analytical biochemistry.

[5]  N. Akizu,et al.  H3K27me3 regulates BMP activity in developing spinal cord , 2010, Development.

[6]  A. Jadhav,et al.  Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors , 2010, PloS one.

[7]  Howard Y. Chang,et al.  A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.

[8]  T. Heightman,et al.  Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates. , 2011, Organic & biomolecular chemistry.

[9]  T. Veenstra,et al.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.

[10]  Peter J. Park,et al.  An assessment of histone-modification antibody quality , 2010, Nature Structural &Molecular Biology.

[11]  U. Oppermann,et al.  Development of homogeneous luminescence assays for histone demethylase catalysis and binding. , 2010, Analytical biochemistry.

[12]  Thomas A Kost,et al.  Baculovirus as versatile vectors for protein expression in insect and mammalian cells , 2005, Nature Biotechnology.

[13]  T. Magnuson,et al.  Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. , 2010, The Journal of clinical investigation.

[14]  I. Issaeva,et al.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development , 2007, Nature.

[15]  Bin Tean Teh,et al.  Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer , 2009, Nature Genetics.

[16]  C. Schofield,et al.  Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II). , 2009, Chemical communications.

[17]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[18]  Terry Magnuson,et al.  Polycomb Repressive Complex 2 Is Dispensable for Maintenance of Embryonic Stem Cell Pluripotency , 2008, Stem cells.

[19]  Nathan L. Avaritt,et al.  MassSQUIRM: an assay for quantitative measurement of lysine demethylase activity , 2011, Epigenetics.

[20]  U. Oppermann,et al.  Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. , 2008, Journal of medicinal chemistry.

[21]  R. Klose,et al.  The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.

[22]  P. Hyttel,et al.  Regulation of H3K27me3 and H3K4me3 during early porcine embryonic development , 2010, Molecular Reproduction and Development.

[23]  A. Weinmann,et al.  Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. , 2010, Molecular cell.

[24]  G. Natoli,et al.  The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.

[25]  Giuseppe Testa,et al.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages , 2009, The EMBO journal.

[26]  C. Chen,et al.  JMJD3 is a histone H3K27 demethylase , 2007, Cell Research.

[27]  K. Jung,et al.  The Role of NF-κB and H3K27me3 Demethylase, Jmjd3, on the Anthrax Lethal Toxin Tolerance of RAW 264.7 Cells , 2010, PloS one.

[28]  John Yu,et al.  Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells* , 2010, The Journal of Biological Chemistry.

[29]  G. Ming,et al.  G9a and Jhdm2a Regulate Embryonic Stem Cell Fusion‐Induced Reprogramming of Adult Neural Stem Cells , 2008, Stem cells.

[30]  Jia Fang,et al.  In vitro histone demethylase assays. , 2009, Methods in molecular biology.

[31]  M. Labow,et al.  KMT1E Mediated H3K9 Methylation Is Required for the Maintenance of Embryonic Stem Cells by Repressing Trophectoderm Differentiation , 2009, Stem cells.

[32]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[33]  M. Mackeen,et al.  Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry. , 2010, Journal of proteome research.

[34]  O. Hermanson,et al.  SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron , 2007, Nature.

[35]  Ye Zhang,et al.  Jmjd3 activates Mash1 gene in RA‐induced neuronal differentiation of P19 cells , 2010, Journal of cellular biochemistry.

[36]  Y. Matsui,et al.  Cellular dynamics associated with the genome-wide epigenetic reprogramming in migrating primordial germ cells in mice , 2007, Development.